032830.KS
Samsung Life Insurance Co., Ltd. [032830.KS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
032830.KS Stock Summary
Top 032830.KS Correlated Resources
032830.KS
Top 10 Correlated ETFs
032830.KS
Top 10 Correlated Stocks
032830.KS
032830.KS Financial details
Company Rating
Strong Buy
Market Cap
12444.55B
Income
708.83B
Revenue
19583.6B
Book val./share
112705.89
Cash/share
-
Dividend
3000
Dividend %
4.25%
Employees
5.04K
Optionable
No
Shortable
Yes
Earnings
20 Feb 2023
P/E
17.89
Forward P/E
-
PEG
-4.07
P/S
0.65
P/B
0.63
P/C
-
P/FCF
19.76
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
3.95K
EPS next Y
-
EPS next Q
-
EPS this Y
16.09%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
4.73%
Revenue last 5Y
-0.26%
Revenue Q/Q
-
EPS Q/Q
-30.34%
-
-
-
-
SMA20
4.17%
SMA50
10.18%
SMA100
17.2%
Inst Own
-
Inst Trans
-
ROA
-
ROE
3%
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
4%
Payout
76%
Shs Outstand
179.58M
Shs Float
89.53M
-
-
-
-
Target Price
-
52W Range
56000.0-73400.0
52W High
-3.81%
52W Low
+26.07%
RSI
49
Rel Volume
1.6
Avg Volume
223.99K
Volume
358.99K
Perf Week
1.29%
Perf Month
7.95%
Perf Quarter
7.95%
Perf Half Y
8.45%
-
-
-
-
Beta
0.932681
-
-
Volatility
1849.66%, 1639.41%
Prev Close
4.13%
Price
70600
Change
3.82%
032830.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 160.96K | 167.18K | 157.96K | 162.1K | 158.86K | |
| Net income per share | 6.49K | 9.27K | 5.44K | 7.05K | 8.18K | |
| Operating cash flow per share | 8.96K | 10.89K | 48.14K | 16.25K | 14.19K | |
| Free cash flow per share | 5.47K | 2K | 46.61K | 15.47K | 13.62K | |
| Cash per share | 43.08K | 848.58K | 964.38K | 1.04M | 1.03M | |
| Book value per share | 163.49K | 160.95K | 198.62K | 233.3K | 210.57K | |
| Tangible book value per share | 167.71K | 165.14K | 203.66K | 239.22K | 217.34K | |
| Share holders equity per share | 163.49K | 160.95K | 198.62K | 233.3K | 210.57K | |
| Interest debt per share | 79.58K | 89.39K | 85.34K | 88.39K | 104.25K | |
| Market cap | 22446.85B | 16736.37B | 12462.49B | 12677.98B | 10846.32B | |
| Enterprise value | 31348.87B | 27600.99B | 20968.96B | 23167.19B | 23156.11B | |
| P/E ratio | 19.25 | 10.06 | 12.75 | 10.02 | 7.38 | |
| Price to sales ratio | 0.78 | 0.56 | 0.44 | 0.44 | 0.38 | |
| POCF ratio | 13.96 | 8.56 | 1.44 | 4.34 | 4.26 | |
| PFCF ratio | 22.83 | 46.69 | 1.49 | 4.56 | 4.43 | |
| P/B Ratio | 0.76 | 0.58 | 0.35 | 0.3 | 0.29 | |
| PTB ratio | 0.76 | 0.58 | 0.35 | 0.3 | 0.29 | |
| EV to sales | 1.08 | 0.92 | 0.74 | 0.8 | 0.81 | |
| Enterprise value over EBITDA | 13.39 | 8.82 | 8.28 | 8.84 | 7.76 | |
| EV to operating cash flow | 19.49 | 14.11 | 2.43 | 7.94 | 9.09 | |
| EV to free cash flow | 31.89 | 76.99 | 2.51 | 8.34 | 9.46 | |
| Earnings yield | 0.05 | 0.1 | 0.08 | 0.1 | 0.14 | |
| Free cash flow yield | 0.04 | 0.02 | 0.67 | 0.22 | 0.23 | |
| Debt to equity | 0.47 | 0.54 | 0.41 | 0.37 | 0.48 | |
| Debt to assets | 0.89 | 0.89 | 0.88 | 0.87 | 0.88 | |
| Net debt to EBITDA | 3.8 | 3.47 | 3.36 | 4 | 4.13 | |
| Current ratio | 0 | 0 | 0 | 0 | 0 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 1.38 | 1.18 | 8.84 | 2.31 | 1.73 | |
| Dividend Yield | 0.01 | 0.03 | 0.04 | 0.04 | 0.05 | |
| Payout ratio | 0.22 | 0.27 | 0.53 | 0.41 | 0.33 | |
| Sales general and administrative to revenue | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.39 | -0.82 | -0.03 | -0.05 | -0.04 | |
| Capex to revenue | -0.02 | -0.05 | -0.01 | 0 | 0 | |
| Capex to depreciation | -2.02 | -4.09 | -0.51 | -0.28 | -0.22 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 154.56K | 183.2K | 155.96K | 192.35K | 196.9K | |
| ROIC | 0 | 0 | 0 | 0 | 0 | |
| Return on tangible assets | 0 | 0.01 | 0 | 0 | 0 | |
| Graham Net | -1.36M | -593.28K | -569.5K | -587.73K | -651.35K | |
| Working capital | 0 | 0 | 0 | 0 | 0 | |
| Tangible asset value | 30117.26B | 29654.85B | 36573.04B | 42957.41B | 39029.18B | |
| Net current asset value | 0 | 0 | 0 | 0 | 0 | |
| Invested capital | 0.47 | 0.54 | 0.41 | 0.37 | 0.48 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 19.51B | 19.85B | 28.73B | 19.83B | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0.04 | 0.06 | 0.03 | 0.03 | 0.04 | |
| Capex per share | -3.48K | -8.9K | -1.53K | -787.87 | -562.34 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
| Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
|---|---|---|---|---|---|---|
| Revenue per share | 39.53K | 34.42K | 35.59K | 39.02K | 0 | |
| Net income per share | 719.41 | 977.42 | 1.5K | 864.79 | 602.58 | |
| Operating cash flow per share | 5.83K | 14.08K | -6.86K | -5.96K | 2.91K | |
| Free cash flow per share | 5.88K | 13.85K | -6.94K | -6.09K | 2.75K | |
| Cash per share | 1.01M | 1.03M | 953.23K | 662.47K | 0 | |
| Book value per share | 208.01K | 210.45K | 165.38K | 122.71K | 112.71K | |
| Tangible book value per share | 214.63K | 217.22K | 172.14K | 129.79K | 123.19K | |
| Share holders equity per share | 208.01K | 210.45K | 165.38K | 122.71K | 112.71K | |
| Interest debt per share | 97.81K | 101.58K | 103.85K | 112.17K | 0 | |
| Market cap | 13180.79B | 11517.32B | 11833.98B | 11241.38B | 11205.47B | |
| Enterprise value | 26285.13B | 23827.11B | 25940.3B | 27113.6B | 11205.47B | |
| P/E ratio | 25.51 | 16.4 | 10.97 | 18.1 | 25.89 | |
| Price to sales ratio | 1.86 | 1.86 | 1.85 | 1.6 | 0 | |
| POCF ratio | 12.59 | 4.55 | -9.61 | -10.51 | 21.43 | |
| PFCF ratio | 12.49 | 4.63 | -9.49 | -10.28 | 22.72 | |
| P/B Ratio | 0.35 | 0.3 | 0.4 | 0.51 | 0.55 | |
| PTB ratio | 0.35 | 0.3 | 0.4 | 0.51 | 0.55 | |
| EV to sales | 3.7 | 3.85 | 4.06 | 3.87 | 0 | |
| Enterprise value over EBITDA | 64.96 | 47.07 | 44.45 | 53.95 | 0 | |
| EV to operating cash flow | 25.1 | 9.42 | -21.07 | -25.34 | 21.43 | |
| EV to free cash flow | 24.91 | 9.57 | -20.81 | -24.78 | 22.72 | |
| Earnings yield | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | |
| Free cash flow yield | 0.08 | 0.22 | -0.11 | -0.1 | 0.04 | |
| Debt to equity | 0.47 | 0.48 | 0.62 | 0.91 | 0 | |
| Debt to assets | 0.88 | 0.88 | 0.9 | 0.92 | 0.93 | |
| Net debt to EBITDA | 32.38 | 24.32 | 24.17 | 31.58 | 0 | |
| Current ratio | 0 | 0 | 0 | 0 | 0 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 8.11 | 14.41 | -4.56 | -6.89 | 4.83 | |
| Dividend Yield | 0 | 0 | 0 | 0.05 | 0 | |
| Payout ratio | 0 | 0 | 0.2 | 3.47 | 0 | |
| Sales general and administrative to revenue | 0.03 | 0.04 | 0.03 | 0.03 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | -0.02 | 0.01 | 0.02 | -0.06 | |
| Capex to revenue | 0 | -0.01 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | -0.35 | -0.13 | -0.2 | -0.25 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 58.03K | 68.03K | 74.76K | 48.86K | 39.09K | |
| ROIC | 0 | 0 | 0 | 0 | 0 | |
| Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
| Graham Net | -644.23K | -650.98K | -698.26K | -958.7K | -1.63M | |
| Working capital | 0 | 0 | 0 | 0 | 0 | |
| Tangible asset value | 38541.43B | 39029.18B | 30912.32B | 23307.54B | 0 | |
| Net current asset value | 0 | 0 | 0 | 0 | 0 | |
| Invested capital | 0.47 | 0.48 | 0.62 | 0.91 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 41.9B | 25.42B | 38.31B | 39.92B | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0 | 0 | 0.01 | 0.01 | 0.01 | |
| Capex per share | 0 | -229.39 | -86.43 | -134.52 | -166.19 |
032830.KS Frequently Asked Questions
What is Samsung Life Insurance Co., Ltd. stock symbol ?
Samsung Life Insurance Co., Ltd. is a US stock and trading under the symbol 032830.KS
What is Samsung Life Insurance Co., Ltd. stock quote today ?
Samsung Life Insurance Co., Ltd. stock price is $70600 today.
Is Samsung Life Insurance Co., Ltd. stock public?
Yes, Samsung Life Insurance Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 223.99K
- Market Capitalization 12444.55B
- Employee 5.04K
- Headquarters Seoul,US
- IPO Date 2010-05-12
-
Website
https://www.samsunglife.com 
Samsung Life Insurance Co., Ltd. engages in the life insurance business in Korea and internationally. The company operates through Domestic Insurance; Credit Card Service, Installment Financing, and Leasing; and Overseas segments. It offers life, term, health, accident, pension, saving, child, and direct insurance; insurance contract, credit, and mortgage loans; and retirement pension products. In addition, the company engages in the provision of real estate lease, investment and trust management, specialized credit finance, collective and real estate collective investment vehicle, and new technology business investment services. As of December 31, 2021, it operated 88 local divisions and 590 branches. The company was incorporated in 1957 and is based in Seoul, South Korea.
